About Reza Dana, MD, MPH, MSC
Dr. Reza Dana is an internationally recognized expert in corneal disorders and ocular inflammation. He is a graduate of Johns Hopkins and Harvard Universities, who holds the Claes Dohlman Chair in Ophthalmology at Harvard Medical School. He is Director of the Cornea Service at the Massachusetts Eye and Ear, Senior Scientist at the Schepens Eye Research Institute/Mass Eye and Ear, and a member of the Harvard Medical School Graduate Program in Immunology (Committee on Immunology), and directs the Harvard-Vision Clinical Scientist Development Program. He conducts both basic and translational research in the field of corneal and transplantation immunology. He studies the molecular and cellular mechanisms of ocular inflammation with applications to autoimmunity, transplantation, dry eye disease and graft-versus-host disease (GVHD).
A Gold Fellow of the Association for Research in Vision and Ophthalmology (ARVO), he has authored more than 390 peer-reviewed articles and over 120 reviews and book chapters, and has presented more than 200 invited and named lectures worldwide. His published work has been cited more than 28,000 times and has an h-index of 86. Dr. Dana's translational research has led to several successful physician-sponsored IND applications to the FDA. His research is supported by several federal grants.
Dr. Dana has trained over 80 clinical fellows, and 125 postdoctoral fellows and students in his laboratory from over 33 countries to date, the significant majority holding full-time academic positions in ophthalmology and vision research. He is recipient of the Harvard Medical School A. Clifford Barger Excellence in Mentoring Award, ARVO's Cogan Award (2003) and ISER's Endre A. Balazs Price (2016), Friedenwald Award (2018) and the Stein Innovation Award from Research to Prevent Blindness.
Clinical Interests:
- Cornea and external diseases
- Uveitis and immunology
Treats:
- Adult
Languages:
- French, Italian
Locations
Mass Eye and Ear
243 Charles St.
Boston, MA 02114
Phone: 617-523-7900
Medical Education
- MSc, Harvard T.H. Chan School of Public Health*
- MD, Johns Hopkins University School of Medicine
- MPH, Johns Hopkins University, School of Public Health
- Residency, Illinois Eye & Ear Infirmary
- Fellowship, Massachusetts Eye and Ear
- Fellowship, Wills Eye Institute
American Board Certifications
- Ophthalmology, American Board of Ophthalmology
Research
Dr. Dana is an ophthalmologist and immunologist whose principal research interest is in determining the molecular and cellular regulation of corneal and ocular surface immunity. His laboratory focuses on the mechanisms by which both immune and non-hematopoietic (tissue resident) cells maintain immune quiescence in both alloimmunity and autoimmunity. Work from the Dana lab has been instrumental in determining the cytokine ligands and receptors (including decoy non-signaling receptors) that maintain the eye's immune and angiogenic privilege. Since these regulatory functions are susceptible to failure in states of high inflammation, the lab has focused on (I) determining the mechanisms that lead to abrogation of the normal regulatory functions of immune cells and (ii) cytokine targeting strategies that can counter-balance these pathogenic mechanisms for restoring immune homeostasis. The work has uncovered numerous mechanisms that regulate antigen-presenting/dendritic cell maturation and mobilization in the eye and lymphoid tissues, interactions between immune cells, including effector and regulatory T cells (Treg), with the ocular surface epithelium and vascular endothelium, and more recently Treg plasticity and regulatory breakdown in chronic inflammation. The group's more recent program is focused on the effect of aging on the Treg-memory T cell balance.
Publications
-
1. Dana R. Letter From the New Editor-in-Chief. Cornea. 2020 Jan; 39(1):1.
2. Coco G, Foulsham W, Nakao T, Yin J, Amouzegar A, Taketani Y, Chauhan SK, Dana R. Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10. AM J Transplant. 2020;20(2):389-398. PMID: 31587452
3. Yu M, Lee SM, Lee H, Amouzegar A, Nakao T, Chen Y, Dana R. Neurokinin-1 receptor antagonism ameliorates dry eye disease by inhibiting antigen-presenting cell maturation and T helper 17 cell antagonism. AM J Pathol. 2020;190:125-133. PMID: 31669306.
4. Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A. Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmol. 2019 Nov 27.
5. Lu??nik Z, Sun Z, Yin J, Benetz BA, Lass JH, Dana R. A standardized methodology for longitudinal assessment of corneal endothelial morphometry in eye banked corneas. J Biol Methods. 2019; 6(4):e120.
I always find Dr. Dana most cordial, responsive, professional, good listener, good communicator.
Dr. Dana and his resident team were pleasant, knowledgeable and professional. They objectively listened as I explained my symptoms. They also answered all my questions and concerns. Dr. Dana implemented a treatment plan of care specific for me. Thank you!
Dr. Dana was superb. I have had graft versus host for eight years and he is the only doctor that I've seen who hasn't told me I was going blind unless I did exactly what I was told to do. So he was wonderful.
Dr. Dana is very knowledgeable, but not good at explaining the "why" to a patient concerning treatments that he recommends. I need to know exactly why I am asked to do something and what the benefit will be. I also want to know the cause of various aspects of my condition. He never responds to such questions in an intelligible manner. ... Read More
He was very knowledgeable and answered all my questions. One of the residents and a tech did most of the work. I only saw the doctor for a few minutes.
Very impressive. I saw a total of one tech and three physicians. All were attentive, thorough and positive. I was very very happy with the whole experience.
Knowledgeable and understanding
He remembered me from treating me about 25 to 18 years ago after my BMT FOR CML
Liked their expert and honest feedback
I expect sometimes things to be easier when you have an issue but no need to go to emergencies as the cost is very high. There should be an option of someone that could give a follow up in case you need to go urgently and be seen when there is an issue like a follow up.